13. Literaturverzeichnis – Larynxkarzinom

1. Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID), Datenbankabfrage zur Inzidenz von Kehlkopftumoren. Datenstand Mai 2017GEKID, 2017.

2. Pantel, M., Guntinas-Lichius, O., Larynxkarzinom: Epidemiologie, Risikofaktoren und Uberleben. [Laryngeal carcinoma: epidemiology, risk factors and survival], HNO, 2012. 60(1): p. 32-40.

3. Robert Koch Institut (RKI), Zentrum für Krebsregisterdaten, Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID), Krebs in Deutschland 2011/2012, 10. AusgabeRKI, 2015.

4. Chatenoud, L., Garavello, W., Pagan, E., Bertuccio, P., Gallus, S., La Vecchia, C., et.al. Laryngeal cancer mortality trends in European countries, Int J Cancer, 2016. 138(4): p. 833-42., https://www.ncbi.nlm.nih.gov/pubmed/26335030

5. Wiegand, S., Evidenz und Evidenzlücken zur Chirurgie des Larynxkarzinoms. [Evidence-Based Review of Laryngeal Cancer Surgery], Laryngorhinootologie, 2016. 95 Suppl 1: p. S192-216.

6. Chatenoud, L., Garavello, W., Pagan, E., Bertuccio, P., Gallus, S., La Vecchia, C., et.al. Laryngeal cancer mortality trends in European countries, Int J Cancer, 2016. 138(4): p. 833-42.

7. International Agency for Research on Cancer (IARC), World Health Organization (WHO), GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. April 2015IARC, 2015.

8. Peller, M., Katalinic, A., Wollenberg, B., Teudt, I. U., Meyer, J. E., Epidemiology of laryngeal carcinoma in Germany, 1998-2011, Eur Arch Otorhinolaryngol, 2016. 273(6): p. 1481-7.

9. National Cancer Institute (NCI), Cancer Stat Facts: Laryngeal CancerNCI, 2017.

10. Talamini, R., Bosetti, C., La Vecchia, C., Dal Maso, L., Levi, F., Bidoli, E., et.al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study, Cancer Causes Control, 2002. 13(10): p. 957-64.

11. Altieri, A., Bosetti, C., Talamini, R., Gallus, S., Franceschi, S., Levi, F., et.al. Cessation of smoking and drinking and the risk of laryngeal cancer, Br J Cancer, 2002. 87(11): p. 1227-9.

12. Corrao, G., Bagnardi, V., Zambon, A., Arico, S., Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis, Addiction, 1999. 94(10): p. 1551-73.

13. Ramroth, H., Dietz, A., Becher, H., Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case-control study from Germany, Methods Inf Med, 2004. 43(5): p. 499-504.

14. Maier, H., Gewelke, U., Dietz, A., Thamm, H., Heller, W. D., Weidauer, H., Kehlkopfkarzinom und Berufstätigkeit - Ergebnisse der Heidelberger Kehlkopfkrebsstudie. [Laryngeal cancer and occupation - results of the Heidelberg laryngeal cancer study], HNO, 1992. 40(2): p. 44-51.

15. Mehrtens, Gerhard, Brandenburg, Stephan, BKV - Die BerufskrankheitenverordnungErich Schmidt Verlag GmbH, ergänzbare Sammlung der Vorschriften, Merkblätter und Materialien Handkommentar aus rechtlicher und medizinischer Sicht für Ärzte, Versicherungsträger und Sozialgerichte, 2018.

16. Soskolne, C. L., Jhangri, G. S., Siemiatycki, J., Lakhani, R., Dewar, R., Burch, J. D., et.al. Occupational exposure to sulfuric acid in southern Ontario, Canada, in association with laryngeal cancer, Scand J Work Environ Health, 1992. 18(4): p. 225-32.

17. Bayer, O., Camara, R., Zeissig, S. R., Ressing, M., Dietz, A., Locati, L. D., et.al. Occupation and cancer of the larynx: a systematic review and meta-analysis, Eur Arch Otorhinolaryngol, 2016. 273(1): p. 9-20.

18. Huebbers, C. U., Preuss, S. F., Kolligs, J., Vent, J., Stenner, M., Wieland, U., et.al. Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis, PLoS One, 2013. 8(2): p. e57207.

19. Omland, T., Lie, K. A., Akre, H., Sandlie, L. E., Jebsen, P., Sandvik, L., et.al. Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia, PLoS One, 2014. 9(6): p. e99114.

20. Kreimer, A. R., Clifford, G. M., Boyle, P., Franceschi, S., Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review, Cancer Epidemiol Biomarkers Prev, 2005. 14(2): p. 467-75.

21. Castellsague, X., Alemany, L., Quer, M., Halec, G., Quiros, B., Tous, S., et.al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients, J Natl Cancer Inst, 2016. 108(6): p. djv403.

22. Mooren, J. J., Gultekin, S. E., Straetmans, J. M., Haesevoets, A., Peutz-Kootstra, C. J., Huebbers, C. U., et.al. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias, Int J Cancer, 2014. 134(9): p. 2108-17.

23. Gultekin, S. E., Senguven, B., Klussmann, J. P., Dienes, H. P., P16(INK 4a) and Ki-67 expression in human papilloma virus-related head and neck mucosal lesions, Invest Clin, 2015. 56(1): p. 47-59.

24. Halec, G., Holzinger, D., Schmitt, M., Flechtenmacher, C., Dyckhoff, G., Lloveras, B., et.al. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma, Br J Cancer, 2013. 109(1): p. 172-83.

25. Mork, J., Lie, A. K., Glattre, E., Hallmans, G., Jellum, E., Koskela, P., et.al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck, N Engl J Med, 2001. 344(15): p. 1125-31.

26. Anantharaman, D., Gheit, T., Waterboer, T., Abedi-Ardekani, B., Carreira, C., McKay-Chopin, S., et.al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study, J Natl Cancer Inst, 2013. 105(8): p. 536-45.

27. Bosetti, C., Gallus, S., Trichopoulou, A., Talamini, R., Franceschi, S., Negri, E., et.al. Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract, Cancer Epidemiol Biomarkers Prev, 2003. 12(10): p. 1091-4.

28. Bosetti, C., Talamini, R., Levi, F., Negri, E., Franceschi, S., Airoldi, L., et.al. Fried foods: a risk factor for laryngeal cancer?, Br J Cancer, 2002. 87(11): p. 1230-3.

29. Levi, F., Pasche, C., Lucchini, F., Chatenoud, L., Jacobs, D. R., Jr., La Vecchia, C., Refined and whole grain cereals and the risk of oral, oesophageal and laryngeal cancer, Eur J Clin Nutr, 2000. 54(6): p. 487-9.

30. Oreggia, F., De Stefani, E., Boffetta, P., Brennan, P., Deneo-Pellegrini, H., Ronco, A. L., Meat, fat and risk of laryngeal cancer: a case-control study in Uruguay, Oral Oncol, 2001. 37(2): p. 141-5.

31. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), Deutsche Gesellschaft für Mund- Kiefer- und Gesichtschirurgie (DGMKG), Diagnostik und Therapie des Mundhöhlenkarzinoms, Version 2.0. AWMF-Register-Nr.: 007-100OLLeitlinienprogramm Onkologie, 2012.

32. Bosetti, C., La Vecchia, C., Talamini, R., Negri, E., Levi, F., Fryzek, J., et.al. Energy, macronutrients and laryngeal cancer risk, Ann Oncol, 2003. 14(6): p. 907-12.

33. Uzcudun, A. E., Retolaza, I. R., Fernandez, P. B., Sanchez Hernandez, J. J., Grande, A. G., Garcia, A. G., et.al. Nutrition and pharyngeal cancer: results from a case-control study in Spain, Head Neck, 2002. 24(9): p. 830-40.

34. Franceschi, S., Favero, A., Conti, E., Talamini, R., Volpe, R., Negri, E., et.al. Food groups, oils and butter, and cancer of the oral cavity and pharynx, Br J Cancer, 1999. 80(3-4): p. 614-20.

35. De Stefani, E., Oreggia, F., Boffetta, P., Deneo-Pellegrini, H., Ronco, A., Mendilaharsu, M., Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: a case-control in Uruguay, Oral Oncol, 2000. 36(1): p. 47-53.

36. Bosetti, C., La Vecchia, C., Talamini, R., Negri, E., Levi, F., Dal Maso, L., et.al. Food groups and laryngeal cancer risk: a case-control study from Italy and Switzerland, Int J Cancer, 2002. 100(3): p. 355-60.

37. Tavani, A., Pelucchi, C., Parpinel, M., Negri, E., Franceschi, S., Levi, F., et.al. n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland, Int J Cancer, 2003. 105(1): p. 113-6.

38. Elahi, A., Zheng, Z., Park, J., Eyring, K., McCaffrey, T., Lazarus, P., The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk, Carcinogenesis, 2002. 23(7): p. 1229-34.

39. Elahi, A., Bendaly, J., Zheng, Z., Muscat, J. E., Richie, J. P., Jr., Schantz, S. P., et.al. Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk, Cancer, 2003. 98(4): p. 872-80.

40. Cheng, L., Sturgis, E. M., Eicher, S. A., Spitz, M. R., Wei, Q., Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck, Cancer, 2002. 94(2): p. 393-7.

41. Zheng, Y., Shen, H., Sturgis, E. M., Wang, L. E., Eicher, S. A., Strom, S. S., et.al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study, Carcinogenesis, 2001. 22(8): p. 1195-9.

42. Zheng, Z., Park, J. Y., Guillemette, C., Schantz, S. P., Lazarus, P., Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk, J Natl Cancer Inst, 2001. 93(18): p. 1411-8.

43. Gale, N., Michaels, L., Luzar, B., Poljak, M., Zidar, N., Fischinger, J., et.al. Current review on squamous intraepithelial lesions of the larynx, Histopathology, 2009. 54(6): p. 639-56.

44. Gale, N., Gnepp, D. R., Poljak, M., Strojan, P., Cardesa, A., Helliwell, T., et.al. Laryngeal Squamous Intraepithelial Lesions: An Updated Review on Etiology, Classification, Molecular Changes, and Treatment, Adv Anat Pathol, 2016. 23(2): p. 84-91.

45. van Hulst, A. M., Kroon, W., van der Linden, E. S., Nagtzaam, L., Ottenhof, S. R., Wegner, I., et.al. Grade of dysplasia and malignant transformation in adults with premalignant laryngeal lesions, Head Neck, 2016. 38 Suppl 1: p. E2284-90.

46. International Agency for Research on Cancer (IARC), World Health Organization (WHO), El-Naggar, A. K., Chan, J. K. C., Grandis, J. R., Takata, T., et.al. WHO Classification of Head and Neck Tumours. Fourth editionWHO, 2017.

47. Slootweg, P. J., Grandis, J. R., Tumours of the hypopharynx, larynx, trachea and parapharyngeal space., in WHO Classification of Head and Neck Tumours. Fourth Edition, International Agency for Research on Cancer (IARC) and World Health Organization (WHO), Editors. 2017, WHO: Lyon. p. 77-104.

48. Neid, M., Tannapfel, A., Intraepitheliale Plattenepithelneoplasie (WHO 2005). Präkanzerose Läsion im Kopf-Hals-Bereich. [Squamous intraepithelial neoplasia (WHO 2005). Precancerous lesions of the head and neck region], HNO, 2009. 57(2): p. 181-7; quiz 188.

49. Macfarlane, G. J., Boyle, P., Scully, C., Oral cancer in Scotland: changing incidence and mortality, BMJ, 1992. 305(6862): p. 1121-3.

50. Department of Dental Services, Screening for oral cancerRoyal College of Surgeons of England, 1994.

51. British Dental Association (BDA), Opportunistic oral cancer screening. BDA occasional paperBDA, 2000.

52. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Gesellschaft für Mund- Kiefer- und Gesichtschirurgie (DGMKG), Diagnostik und Management von Mundschleimhautveränderungen, insbesondere von Vorläuferläsionen des oralen Plattenepithelkarzinoms in der Zahn-, Mund- und Kieferheilkunde. S2k-LeitlinieAWMF, 2010.

53. Zheng, Z., Park, J. Y., Guillemette, C., Schantz, S. P., Lazarus, P., Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk, J Natl Cancer Inst, 2001. 93(18): p. 1411-8.

54. International Agency for Research on Cancer (IARC), World Health Organization (WHO), El-Naggar, A. K., Chan, J. K. C., Grandis, J. R., Takata, T., et.al. WHO Classification of Head and Neck Tumours. Fourth editionWHO, 2017.

55. Neid, M., Tannapfel, A., Intraepitheliale Plattenepithelneoplasie (WHO 2005). Präkanzerose Läsion im Kopf-Hals-Bereich. [Squamous intraepithelial neoplasia (WHO 2005). Precancerous lesions of the head and neck region], HNO, 2009. 57(2): p. 181-7; quiz 188.

56. Brandstorp-Boesen, J., Sorum Falk, R., Boysen, M., Brondbo, K., Impact of stage, management and recurrence on survival rates in laryngeal cancer, PLoS One, 2017. 12(7): p. e0179371.

57. van Dijk, B. A., Karim-Kos, H. E., Coebergh, J. W., Marres, H. A., de Vries, E., Progress against laryngeal cancer in The Netherlands between 1989 and 2010, Int J Cancer, 2014. 134(3): p. 674-81.

58. Brierley, J. D., Gospodarowicz, M. K., Wittekind, C., TNM Classification of Malignant Tumours. Eigth EditionJohn Wiley & Sons, 2016.

59. Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsague, X., Laporte, L., et.al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis, Lancet Oncol, 2014. 15(12): p. 1319-31.

60. Lassen, P., Primdahl, H., Johansen, J., Kristensen, C. A., Andersen, E., Andersen, L. J., et.al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer, Radiother Oncol, 2014. 113(3): p. 310-6.

61. Young, R. J., Urban, D., Angel, C., Corry, J., Lyons, B., Vallance, N., et.al. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma, Br J Cancer, 2015. 112(6): p. 1098-104.

62. Cancer Genome Atlas Network, Comprehensive genomic characterization of head and neck squamous cell carcinomas, Nature, 2015. 517(7536): p. 576-82.

63. Kostareli, E., Hielscher, T., Zucknick, M., Baboci, L., Wichmann, G., Holzinger, D., et.al. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients, Epigenetics, 2016. 11(1): p. 61-73.

64. Agaimy, A., Weichert, W., Grading von Tumoren der Kopf-Hals-Region. [Grading of head and neck neoplasms], Pathologe, 2016. 37(4): p. 285-92.

65. Bundesverband Deutscher Pathologen, Deutsche Gesellschaft für Pathologie, S1-Leitlinie zur pathologisch-anatomischen Diagnostik von Plattenepithelkarzinomen des Kopf-Hals-BereichesBDP, 2017.

66. Byers, R. M., El-Naggar, A. K., Lee, Y. Y., Rao, B., Fornage, B., Terry, N. H., et.al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?, Head Neck, 1998. 20(2): p. 138-44.

67. Coatesworth, A. P., MacLennan, K., Squamous cell carcinoma of the upper aerodigestive tract: the prevalence of microscopic extracapsular spread and soft tissue deposits in the clinically N0 neck, Head Neck, 2002. 24(3): p. 258-61.

68. Brasilino de Carvalho, M., Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx, Head Neck, 1998. 20(1): p. 16-21.

69. Tankere, F., Camproux, A., Barry, B., Guedon, C., Depondt, J., Gehanno, P., Prognostic value of lymph node involvement in oral cancers: a study of 137 cases, Laryngoscope, 2000. 110(12): p. 2061-5.

70. Woolgar, J. A., Rogers, S. N., Lowe, D., Brown, J. S., Vaughan, E. D., Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread, Oral Oncol, 2003. 39(2): p. 130-7.

71. Suoglu, Y., Erdamar, B., Katircioglu, O. S., Karatay, M. C., Sunay, T., Extracapsular spread in ipsilateral neck and contralateral neck metastases in laryngeal cancer, Ann Otol Rhinol Laryngol, 2002. 111(5 Pt 1): p. 447-54.

72. Greenberg, J. S., Fowler, R., Gomez, J., Mo, V., Roberts, D., El Naggar, A. K., et.al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer, Cancer, 2003. 97(6): p. 1464-70.

73. Esposito, E. D., Motta, S., Cassiano, B., Motta, G., Occult lymph node metastases in supraglottic cancers of the larynx, Otolaryngol Head Neck Surg, 2001. 124(3): p. 253-7.

74. Enepekides, D. J., Sultanem, K., Nguyen, C., Shenouda, G., Black, M. J., Rochon, L., Occult cervical metastases: immunoperoxidase analysis of the pathologically negative neck, Otolaryngol Head Neck Surg, 1999. 120(5): p. 713-7.

75. Ferlito, A., Partridge, M., Brennan, J., Hamakawa, H., Lymph node micrometastases in head and neck cancer: a review, Acta Otolaryngol, 2001. 121(6): p. 660-5.

76. Ansarin, M., Santoro, L., Cattaneo, A., Massaro, M. A., Calabrese, L., Giugliano, G., et.al. Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation, Arch Otolaryngol Head Neck Surg, 2009. 135(4): p. 385-90.

77. Lucioni, M., Bertolin, A., Rizzotto, G., Accordi, D., Giacomelli, L., Marioni, G., CO(2) laser surgery in elderly patients with glottic carcinoma: univariate and multivariate analyses of results, Head Neck, 2012. 34(12): p. 1804-9.

78. Alicandri-Ciufelli, M., Bonali, M., Piccinini, A., Marra, L., Ghidini, A., Cunsolo, E. M., et.al. Surgical margins in head and neck squamous cell carcinoma: what is 'close'?, Eur Arch Otorhinolaryngol, 2013. 270(10): p. 2603-9.

79. Langendijk, J. A., Slotman, B. J., van der Waal, I., Doornaert, P., Berkof, J., Leemans, C. R., Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy, Cancer, 2005. 104(7): p. 1408-17.

80. Gallo, A., Manciocco, V., Simonelli, M., Pagliuca, G., D'Arcangelo, E., de Vincentiis, M., Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors, Arch Otolaryngol Head Neck Surg, 2005. 131(7): p. 620-5.

81. Thurnher, D., Erovic, B. M., Frommlet, F., Brannath, W., Ehrenberger, K., Jansen, B., et.al. Challenging a dogma--surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy, Eur J Surg Oncol, 2008. 34(6): p. 692-8.

82. Steiner, W., Krebsvorsorge und -früherkennung in den oberen Luft- und Speisewegen. Ergebnisse und Folgerungen aus drei Feldstudien, MD GBK, 1988. 53: p. 25-31.

83. Shuman, A. G., Entezami, P., Chernin, A. S., Wallace, N. E., Taylor, J. M., Hogikyan, N. D., Demographics and efficacy of head and neck cancer screening, Otolaryngol Head Neck Surg, 2010. 143(3): p. 353-60.

84. Lohler, J., Gerstner, A. O., Bootz, F., Walther, L. E., Incidence and localization of abnormal mucosa findings in patients consulting ENT outpatient clinics and data analysis of a cancer registry, Eur Arch Otorhinolaryngol, 2014. 271(5): p. 1289-97.

85. Arens, C., Vorwerk, U., Just, T., Betz, C. S., Kraft, M., Fortschritte der endoskopischen Diagnostik von Dysplasien und Karzinomen des Larynx. [Advances in endoscopic diagnosis of dysplasia and carcinoma of the larynx], HNO, 2012. 60(1): p. 44-52.

86. Unger, J., Lohscheller, J., Reiter, M., Eder, K., Betz, C. S., Schuster, M., A noninvasive procedure for early-stage discrimination of malignant and precancerous vocal fold lesions based on laryngeal dynamics analysis, Cancer Res, 2015. 75(1): p. 31-9.

87. Regeling, B., Thies, B., Gerstner, A. O., Westermann, S., Muller, N. A., Bendix, J., et.al. Hyperspectral Imaging Using Flexible Endoscopy for Laryngeal Cancer Detection, Sensors (Basel), 2016. 16(8):

88. Kraft, M., Arens, C., Betz, C., Fostiropoulos, K., Fluoreszenzbildgebung in der Laryngologie: Physikalische Grundlagen, klinische Anwendung und Studienergebnisse. [Fluorescence imaging in laryngology: Physical principles, clinical applications and study results], HNO, 2016. 64(1): p. 4-12.

89. Gogarty, D. S., Shuman, A., O'Sullivan, E. M., Sheahan, P., Kinsella, J., Timon, C., et.al. Conceiving a national head and neck cancer screening programme, J Laryngol Otol, 2016. 130(1): p. 8-14.

90. Breau, R. L., Suen, J. Y., Management of the N(0) neck, Otolaryngol Clin North Am, 1998. 31(4): p. 657-69.

91. Redaelli de Zinis, L. O., Nicolai, P., Tomenzoli, D., Ghizzardi, D., Trimarchi, M., Cappiello, J., et.al. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications, Head Neck, 2002. 24(10): p. 913-20.

92. Banko, B., Dukic, V., Milovanovic, J., Kovac, J. D., Artiko, V., Maksimovic, R., Diagnostic significance of magnetic resonance imaging in preoperative evaluation of patients with laryngeal tumors, Eur Arch Otorhinolaryngol, 2011. 268(11): p. 1617-23.

93. Barbosa, M. M., Araujo, V. J., Jr., Boasquevisque, E., Carvalho, R., Romano, S., Lima, R. A., et.al. Anterior vocal commissure invasion in laryngeal carcinoma diagnosis, Laryngoscope, 2005. 115(4): p. 724-30.

94. Hu, Q., Zhu, S. Y., Zhang, Z., Luo, F., Mao, Y. P., Guan, X. H., Assessment of glottic squamous cell carcinoma: comparison of sonography and non-contrast-enhanced magnetic resonance imaging, J Ultrasound Med, 2011. 30(11): p. 1467-74.

95. Lim, J. Y., Park, I. S., Park, S. W., Kim, J. W., Kim, Y. M., Potential pitfalls and therapeutic implications of pretherapeutic radiologic staging in glottic cancers, Acta Otolaryngol, 2011. 131(8): p. 869-75.

96. Zbaren, P., Becker, M., Lang, H., Staging of laryngeal cancer: endoscopy, computed tomography and magnetic resonance versus histopathology, Eur Arch Otorhinolaryngol, 1997. 254 Suppl 1: p. S117-22.

97. Piazza, C., Cocco, D., De Benedetto, L., Del Bon, F., Nicolai, P., Peretti, G., Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients, Eur Arch Otorhinolaryngol, 2010. 267(3): p. 409-14.

98. Li, B., Bobinski, M., Gandour-Edwards, R., Farwell, D. G., Chen, A. M., Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation, Br J Radiol, 2011. 84(997): p. 64-9.

99. Chaturvedi, P., Datta, S., Arya, S., Rangarajan, V., Kane, S. V., Nair, D., et.al. Prospective study of ultrasound-guided fine-needle aspiration cytology and sentinel node biopsy in the staging of clinically negative T1 and T2 oral cancer, Head Neck, 2015. 37(10): p. 1504-8.

100. Verikas, A., Uloza, V., Bacauskiene, M., Gelzinis, A., Kelertas, E., Advances in laryngeal imaging, Eur Arch Otorhinolaryngol, 2009. 266(10): p. 1509-20.

101. Blitz, A. M., Aygun, N., Radiologic evaluation of larynx cancer, Otolaryngol Clin North Am, 2008. 41(4): p. 697-713, vi.

102. Lell, M. M., Greess, H., Hothorn, T., Janka, R., Bautz, W. A., Baum, U., Multiplanar functional imaging of the larynx and hypopharynx with multislice spiral CT, Eur Radiol, 2004. 14(12): p. 2198-205., https://www.ncbi.nlm.nih.gov/pubmed/15480691

103. Jager, E. A., Kasperts, N., Caldas-Magalhaes, J., Philippens, M. E., Pameijer, F. A., Terhaard, C. H., et.al. GTV delineation in supraglottic laryngeal carcinoma: interobserver agreement of CT versus CT-MR delineation, Radiat Oncol, 2015. 10: p. 26.

104. Banko, B., Djukic, V., Milovanovic, J., Kovac, J., Novakovic, Z., Maksimovic, R., MRI in evaluation of neoplastic invasion into preepiglottic and paraglottic space, Auris Nasus Larynx, 2014. 41(5): p. 471-4.

105. Ryu, I. S., Lee, J. H., Roh, J. L., Choi, S. H., Nam, S. Y., Kim, S. Y., et.al. Clinical implication of computed tomography findings in patients with locally advanced squamous cell carcinoma of the larynx and hypopharynx, Eur Arch Otorhinolaryngol, 2015. 272(10): p. 2939-45.

106. Becker, M., Zbaren, P., Laeng, H., Stoupis, C., Porcellini, B., Vock, P., Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation, Radiology, 1995. 194(3): p. 661-9.

107. Fernandes, R., Gopalan, P., Spyridakou, C., Joseph, G., Kumar, M., Predictive indicators for thyroid cartilage involvement in carcinoma of the larynx seen on spiral computed tomography scans, J Laryngol Otol, 2006. 120(10): p. 857-60.

108. Xia, C. X., Zhu, Q., Zhao, H. X., Yan, F., Li, S. L., Zhang, S. M., Usefulness of ultrasonography in assessment of laryngeal carcinoma, Br J Radiol, 2013. 86(1030): p. 20130343.

109. Kinshuck, A. J., Goodyear, P. W., Lancaster, J., Roland, N. J., Jackson, S., Hanlon, R., et.al. Accuracy of magnetic resonance imaging in diagnosing thyroid cartilage and thyroid gland invasion by squamous cell carcinoma in laryngectomy patients, J Laryngol Otol, 2012. 126(3): p. 302-6.

110. Becker, M., Zbaren, P., Casselman, J. W., Kohler, R., Dulguerov, P., Becker, C. D., Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging, Radiology, 2008. 249(2): p. 551-9.

111. Taha, M. S., Hassan, O., Amir, M., Taha, T., Riad, M. A., Diffusion-weighted MRI in diagnosing thyroid cartilage invasion in laryngeal carcinoma, Eur Arch Otorhinolaryngol, 2014. 271(9): p. 2511-6.

112. Tibbetts, K. M., Tan, M., Role of Advanced Laryngeal Imaging in Glottic Cancer: Early Detection and Evaluation of Glottic Neoplasms, Otolaryngol Clin North Am, 2015. 48(4): p. 565-84.

113. Allegra, E., Ferrise, P., Trapasso, S., Trapuzzano, O., Barca, A., Tamburrini, S., et.al. Early glottic cancer: role of MRI in the preoperative staging, Biomed Res Int, 2014. 2014: p. 890385.

114. Haerle, S. K., Schmid, D. T., Ahmad, N., Hany, T. F., Stoeckli, S. J., The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma, Oral Oncol, 2011. 47(7): p. 653-9.

115. Mehanna, H., Wong, W. L., McConkey, C. C., Rahman, J. K., Robinson, M., Hartley, A. G., et.al. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer, N Engl J Med, 2016. 374(15): p. 1444-54.

116. Minovi, A., Hertel, A., Ural, A., Hofmann, E., Draf, W., Bockmuehl, U., Is PET superior to MRI in the pretherapeutic evaluation of head and neck squamous cell carcinoma?, Kulak Burun Bogaz Ihtis Derg, 2007. 17(6): p. 324-8.

117. Ozer, E., Naiboglu, B., Meacham, R., Ryoo, C., Agrawal, A., Schuller, D. E., The value of PET/CT to assess clinically negative necks, Eur Arch Otorhinolaryngol, 2012. 269(11): p. 2411-4.

118. Richard, C., Prevot, N., Timoshenko, A. P., Dumollard, J. M., Dubois, F., Martin, C., et.al. Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?, Acta Otolaryngol, 2010. 130(12): p. 1421-4.

119. Ha, P. K., Hdeib, A., Goldenberg, D., Jacene, H., Patel, P., Koch, W., et.al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma, Arch Otolaryngol Head Neck Surg, 2006. 132(1): p. 12-6.

120. Scott, A. M., Gunawardana, D. H., Bartholomeusz, D., Ramshaw, J. E., Lin, P., PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study, J Nucl Med, 2008. 49(10): p. 1593-600.

121. Connell, C. A., Corry, J., Milner, A. D., Hogg, A., Hicks, R. J., Rischin, D., et.al. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma, Head Neck, 2007. 29(11): p. 986-95.

122. Kyzas, P. A., Evangelou, E., Denaxa-Kyza, D., Ioannidis, J. P., 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis, J Natl Cancer Inst, 2008. 100(10): p. 712-20.

123. Godeny, M., Lengyel, Z., Polony, G., Nagy, Z. T., Lerant, G., Zambo, O., et.al. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis, Cancer Imaging, 2016. 16(1): p. 38.

124. Moller, A. K., Loft, A., Berthelsen, A. K., Pedersen, K. D., Graff, J., Christensen, C. B., et.al. A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site, Oncologist, 2012. 17(9): p. 1146-54.

125. Lee, C. I., Cevik, M., Alagoz, O., Sprague, B. L., Tosteson, A. N., Miglioretti, D. L., et.al. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts, Radiology, 2015. 274(3): p. 772-80.

126. Davidson, J., Gilbert, R., Irish, J., Witterick, I., Brown, D., Birt, D., et.al. The role of panendoscopy in the management of mucosal head and neck malignancy-a prospective evaluation, Head Neck, 2000. 22(5): p. 449-54; discussion 454-5.

127. Di Martino, E., Rieger, M., Hassan, H. A., Hausmann, R., Reinecke, T., Lohmann, M., et.al. Zur Problematik multipler primärer Karzinome bei Patienten mit Kopf-Hals-Malignomen. [Multiple primary carcinomas in patients with head and neck malignancies], Laryngorhinootologie, 2000. 79(12): p. 711-8.

128. Haughey, B. H., Gates, G. A., Arfken, C. L., Harvey, J., Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol, Ann Otol Rhinol Laryngol, 1992. 101(2 Pt 1): p. 105-12.

129. Kim, M. K., Deschler, D. G., Hayden, R. E., Flexible esophagoscopy as part of routine panendoscopy in ENT resident and fellowship training, Ear Nose Throat J, 2001. 80(1): p. 49-50.

130. Stoeckli, S. J., Zimmermann, R., Schmid, S., Role of routine panendoscopy in cancer of the upper aerodigestive tract, Otolaryngol Head Neck Surg, 2001. 124(2): p. 208-12.

131. Sjogren, E. V., Snijder, S., van Beekum, J., Baatenburg de Jong, R. J., Second malignant neoplasia in early (TIS-T1) glottic carcinoma, Head Neck, 2006. 28(6): p. 501-7.

132. Thompson, C. F., St John, M. A., Lawson, G., Grogan, T., Elashoff, D., Mendelsohn, A. H., Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis, Eur Arch Otorhinolaryngol, 2013. 270(7): p. 2115-22.

133. Yoshimoto, S., Hasegawa, Y., Matsuzuka, T., Shiotani, A., Takahashi, K., Kohno, N., et.al. Sentinel node biopsy for oral and laryngopharyngeal squamous cell carcinoma: a retrospective study of 177 patients in Japan, Auris Nasus Larynx, 2012. 39(1): p. 65-70.

134. Lawson, G., Matar, N., Nollevaux, M. C., Jamart, J., Krug, B., Delos, M., et.al. Reliability of sentinel node technique in the treatment of N0 supraglottic laryngeal cancer, Laryngoscope, 2010. 120(11): p. 2213-7.

135. Werner, J. A., Dunne, A. A., Ramaswamy, A., Folz, B. J., Lippert, B. M., Moll, R., et.al. Sentinel node detection in N0 cancer of the pharynx and larynx, Br J Cancer, 2002. 87(7): p. 711-5.

136. Werner, J. A., Dunne, A. A., Ramaswamy, A., Brandt, D., Kulkens, C., Folz, B. J., et.al. Das Sentinel-Node-Konzept bei Plattenepithelkarzinomen der oberen Luft- und Speisewege - eine kritische Analyse an 100 Patienten. [The sentinel node concept in head and neck squamous cell carcinoma - a critical analysis in 100 patients], Laryngorhinootologie, 2002. 81(1): p. 31-9.

137. Parzeller, M., Wenk, M., Zedler, B., Rothschild, M., Aufklärung und Einwilligung bei ärztlichen Eingriffen, Dtsch Arztebl, 2007. 104(9): p. A-576-86.

138. Gaissmaier, W., Gigerenzer, G., Statistical illiteracy undermines informed shared decision making, Z Evid Fortbild Qual Gesundhwes, 2008. 102(7): p. 411-3.

139. Gigerenzer, G., Gaissmaier, W., Kurz-Milcke, E., Schwartz, L. M., Woloshin, S., Helping Doctors and Patients Make Sense of Health Statistics, Psychol Sci Public Interest, 2007. 8(2): p. 53-96.

140. Gesetz zur Verbesserung der Rechte von Patientinnen und Patienten vom 20. Februar, 2013.

141. Schenck, D. P., Ethical considerations in the treatment of head and neck cancer, Cancer Control, 2002. 9(5): p. 410-9.

142. Hall, G. L., Kademani, D., Risk, J. M., Shaw, R. J., Tissue banking in head and neck cancer, Oral Oncol, 2008. 44(2): p. 109-15.

143. Sheng, X., Zhang, S., Song, X., Chen, L., Luo, X., [Meta-analysis on the risk factors for stomal recurrence after total laryngectomy], Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2013. 27(18): p. 995-9.

144. Zbaren, P., Greiner, R., Kengelbacher, M., Stoma recurrence after laryngectomy: an analysis of risk factors, Otolaryngol Head Neck Surg, 1996. 114(4): p. 569-75.

145. Basheeth, N., O'Leary, G., Khan, H., Sheahan, P., Oncologic outcomes of total laryngectomy: impact of margins and preoperative tracheostomy, Head Neck, 2015. 37(6): p. 862-9.

146. Imauchi, Y., Ito, K., Takasago, E., Nibu, K., Sugasawa, M., Ichimura, K., Stomal recurrence after total laryngectomy for squamous cell carcinoma of the larynx, Otolaryngol Head Neck Surg, 2002. 126(1): p. 63-6.

147. Esteller, E., Aguero, A., Martel, M., Lopez, M., Quer, M., Leon, X., Stomal recurrence in head and neck cancer patients with temporary tracheostomy, Auris Nasus Larynx, 2014. 41(5): p. 467-70.

148. Onakoya, P. A., Nwaorgu, O. G., Kokong, D. D., Adeosun, A. A., Ayodele, K. J., Stomal recurrence post laryngectomy in University College Hospital, Ibadan, Afr J Med Med Sci, 2004. 33(1): p. 65-8.

149. Schariatzadeh, R., Pezier, T. F., Studer, G., Schmid, S., Huber, G. F., Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?, Swiss Med Wkly, 2015. 145: p. w14213.

150. Hilgers, F. J., Ackerstaff, A. H., Van As, C. J., Balm, A. J., Van den Brekel, M. W., Tan, I. B., Development and clinical assessment of a heat and moisture exchanger with a multi-magnet automatic tracheostoma valve (Provox FreeHands HME) for vocal and pulmonary rehabilitation after total laryngectomy, Acta Otolaryngol, 2003. 123(1): p. 91-9.

151. Ackerstaff, A. H., Hilgers, F. J., Balm, A. J., Tan, I. B., Long-term compliance of laryngectomized patients with a specialized pulmonary rehabilitation device: Provox Stomafilter, Laryngoscope, 1998. 108(2): p. 257-60.

152. Dong, P., Li, X., Xie, J., Li, L., Xu, H., Modified frontolateral partial laryngectomy without tracheotomy, Otolaryngol Head Neck Surg, 2009. 141(1): p. 70-4.

153. Alajmo, E., Fini-Storchi, O., Agostini, V., Polli, G., Conservation surgery for cancer of the larynx in the elderly, Laryngoscope, 1985. 95(2): p. 203-5.

154. Clayburgh, D. R., Graville, D. J., Palmer, A. D., Schindler, J. S., Factors associated with supracricoid laryngectomy functional outcomes, Head Neck, 2013. 35(10): p. 1397-403.

155. Naudo, P., Laccourreye, O., Weinstein, G., Jouffre, V., Laccourreye, H., Brasnu, D., Complications and functional outcome after supracricoid partial laryngectomy with cricohyoidoepiglottopexy, Otolaryngol Head Neck Surg, 1998. 118(1): p. 124-9.

156. Decotte, A., Woisard, V., Percodani, J., Pessey, J. J., Serrano, E., Vergez, S., Respiratory complications after supracricoid partial laryngectomy, Eur Arch Otorhinolaryngol, 2010. 267(9): p. 1415-21.

157. Schindler, A., Favero, E., Capaccio, P., Albera, R., Cavalot, A. L., Ottaviani, F., Supracricoid laryngectomy: age influence on long-term functional results, Laryngoscope, 2009. 119(6): p. 1218-25.

158. Alterio, D., Ansarin, M., Jereczek-Fossa, B. A., Zorzi, S., Santoro, L., Zerini, D., et.al. What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long-term outcome for partial laryngectomy followed by radiotherapy in 32 patients, Tumori, 2013. 99(6): p. 667-75.

159. Thomas, L., Drinnan, M., Natesh, B., Mehanna, H., Jones, T., Paleri, V., Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature, Cancer Treat Rev, 2012. 38(3): p. 203-11.

160. Goeleven, A., Dejaeger, E., Vander Poorten, V., Delaere, P., Swallowing and functional outcome after partial laryngectomy: a literature review, B-ENT, 2005. 1(4): p. 165-72.

161. Schröder, U., Offene horizontale Kehlkopfteilresektion und Cricohyoidoglottopexie, in Kopf-Hals-Tumoren - Therapie des Larynx-/Hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts, Dietz, A. , Editor. 2010, Uni-Med: Bremen. p. 93-99.

162. Lips, M., Speyer, R., Zumach, A., Kross, K. W., Kremer, B., Supracricoid laryngectomy and dysphagia: A systematic literature review, Laryngoscope, 2015. 125(9): p. 2143-56.

163. Abdurehim, Y., Hua, Z., Yasin, Y., Xukurhan, A., Imam, I., Yuqin, F., Transoral laser surgery versus radiotherapy: systematic review and meta-analysis for treatment options of T1a glottic cancer, Head Neck, 2012. 34(1): p. 23-33.

164. Birchall, M., EaStER - early stage glottic cancer: endoscopic excision for radiotherapy: a feasibility study. National Research Register N0212194189, 2005.

165. Feng, Y., Wang, B., Wen, S., Laser surgery versus radiotherapy for T1-T2N0 glottic cancer: a meta-analysis, ORL J Otorhinolaryngol Relat Spec, 2011. 73(6): p. 336-42.

166. Greulich, M. T., Parker, N. P., Lee, P., Merati, A. L., Misono, S., Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis, Otolaryngol Head Neck Surg, 2015. 152(5): p. 811-9.

167. Higgins, K. M., Shah, M. D., Ogaick, M. J., Enepekides, D., Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy, J Otolaryngol Head Neck Surg, 2009. 38(6): p. 603-12.

168. Ogoltsova, E.S.;, [Comparative evaluation of the efficacy of radiotherapy, surgery and combined treatment of stage I-II laryngeal cancer (T1-2N0M0) on the basis of co-operative studies], Vestn Otorinolaringol, 1990. 3: p. 3-7.

169. Warner, L., Chudasama, J., Kelly, C. G., Loughran, S., McKenzie, K., Wight, R., et.al. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer, Cochrane Database Syst Rev, 2014. p. CD002027.

170. Yoo, J., Lacchetti, C., Hammond, J. A., Gilbert, R. W., Head, Neck Cancer Disease Site, Group, Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: a systematic review, Head Neck, 2014. 36(12): p. 1807-19.

171. Arens, C., Transorale Therapiestrategien bei Kopf-Hals-Tumoren. [Transoral treatment strategies in head and neck tumors], Laryngorhinootologie, 2012. 91 Suppl 1: p. S86-101.

172. Stoeckli, S. J., Schnieper, I., Huguenin, P., Schmid, S., Early glottic carcinoma: treatment according patient's preference?, Head Neck, 2003. 25(12): p. 1051-6.

173. Coman, W. B., Hendrkz, J. K., Hickey, B., Cahill, L., Hancock, K., Dutkowski, K., et.al. Laser Surgery for early glottis cancer, Head Neck Surg ANZ J Surg, 2003. 73(Suppl. 1): p. A57.

174. Hamilton, D. W., de Salis, I., Donovan, J. L., Birchall, M., The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer, Eur Arch Otorhinolaryngol, 2013. 270(8): p. 2333-7.

175. Mo, H. L., Li, J., Yang, X., Zhang, F., Xiong, J. W., Yang, Z. L., et.al. Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis, Lasers Med Sci, 2017. 32(2): p. 461-467.

176. Canis, M., Martin, A., Ihler, F., Wolff, H. A., Kron, M., Matthias, C., et.al. Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients, Eur Arch Otorhinolaryngol, 2013. 270(8): p. 2315-26.

177. Ambrosch, P., Rödel, R., Kron, M., Steiner, W., Die transorale Lasermikrochirurgie des Larynxkarzinoms. Eine retrospektive Analyse von 657 Patientenverläufen, Onkologe, 2001. 7: p. 505-512.

178. Grant, D. G., Salassa, J. R., Hinni, M. L., Pearson, B. W., Hayden, R. E., Perry, W. C., Transoral laser microsurgery for carcinoma of the supraglottic larynx, Otolaryngol Head Neck Surg, 2007. 136(6): p. 900-6.

179. Iro, H., Waldfahrer, F., Altendorf-Hofmann, A., Weidenbecher, M., Sauer, R., Steiner, W., Transoral laser surgery of supraglottic cancer: follow-up of 141 patients, Arch Otolaryngol Head Neck Surg, 1998. 124(11): p. 1245-50.

180. Ambrosch, P., Fazel, A., Funktionserhaltende Therapie des Kehlkopf- und des Hypopharynxkarzinoms. [Functional organ preservation in laryngeal and hypopharyngeal cancer], Laryngorhinootologie, 2011. 90 Suppl 1: p. S83-109.

181. Motta, G., Esposito, E., Testa, D., Iovine, R., Motta, S., CO2 laser treatment of supraglottic cancer, Head Neck, 2004. 26(5): p. 442-6.

182. Pantazis, D., Liapi, G., Kostarelos, D., Kyriazis, G., Pantazis, T. L., Riga, M., Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery, Eur Arch Otorhinolaryngol, 2015. 272(8): p. 1983-90.

183. Breda, E., Catarino, R., Monteiro, E., Transoral laser microsurgery for laryngeal carcinoma: Survival analysis in a hospital-based population, Head Neck, 2015. 37(8): p. 1181-6.

184. Blanchard, P., Baujat, B., Holostenco, V., Bourredjem, A., Baey, C., Bourhis, J., et.al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site, Radiother Oncol, 2011. 100(1): p. 33-40.

185. Forastiere, A. A., Goepfert, H., Maor, M., Pajak, T. F., Weber, R., Morrison, W., et.al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, N Engl J Med, 2003. 349(22): p. 2091-8.

186. Forastiere, A. A., Zhang, Q., Weber, R. S., Maor, M. H., Goepfert, H., Pajak, T. F., et.al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer, J Clin Oncol, 2013. 31(7): p. 845-52.

187. Pignon, J. P., le Maitre, A., Maillard, E., Bourhis, J., Group, Mach-Nc Collaborative, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 2009. 92(1): p. 4-14.

188. Bonner, J. A., Harari, P. M., Giralt, J., Cohen, R. B., Jones, C. U., Sur, R. K., et.al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival, Lancet Oncol, 2010. 11(1): p. 21-8.

189. Bourhis, J., Sire, C., Graff, P., Gregoire, V., Maingon, P., Calais, G., et.al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial, Lancet Oncol, 2012. 13(2): p. 145-53.

190. Budach, V., Stromberger, C., Poettgen, C., Baumann, M., Budach, W., Grabenbauer, G., et.al. Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial, Int J Radiat Oncol Biol Phys, 2015. 91(5): p. 916-24.

191. Budach, V., Stuschke, M., Budach, W., Baumann, M., Geismar, D., Grabenbauer, G., et.al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial, J Clin Oncol, 2005. 23(6): p. 1125-35.

192. Strojan, P., Vermorken, J. B., Beitler, J. J., Saba, N. F., Haigentz, M., Jr., Bossi, P., et.al. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review, Head Neck, 2016. 38 Suppl 1: p. E2151-8.

193. Budach, W., Bolke, E., Kammers, K., Gerber, P. A., Orth, K., Gripp, S., et.al. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials, Radiother Oncol, 2016. 118(2): p. 238-43.

194. Lefebvre, J. L., Pointreau, Y., Rolland, F., Alfonsi, M., Baudoux, A., Sire, C., et.al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study, J Clin Oncol, 2013. 31(7): p. 853-9.

195. Janoray, G., Pointreau, Y., Garaud, P., Chapet, S., Alfonsi, M., Sire, C., et.al. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, +/- Docetaxel for Larynx Preservation, J Natl Cancer Inst, 2016. 108(4):

196. Dietz, Andreas, Wichmann, Gunnar, Flentje, Michael, Hagen, Rudolf, Koelbl, Oliver, Schreiber, Frank, et.al. Final results of the randomized phase II DeLOS-II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC), Journal of Clinical Oncology, 2016. 34(15_suppl): p. 6025-6025.

197. Bonner, J., Giralt, J., Harari, P., Spencer, S., Schulten, J., Hossain, A., et.al. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial, JAMA Otolaryngol Head Neck Surg, 2016. 142(9): p. 842-9.

198. Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., et.al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis, Lancet, 2006. 368(9538): p. 843-54.

199. Winquist, E., Cripps, C., Agbassi, C., Epidermal growth factor receptor (EGFR) targeted therapy in stage III and IV head and neck cancer. Evidence-Based Series No. 5-12, Version 2.1Cancer Care Ontario (CCO), 2011.

200. Seiwert, T. Y., Cohen, E. E., State-of-the-art management of locally advanced head and neck cancer, Br J Cancer, 2005. 92(8): p. 1341-8.

201. Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., et.al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer, N Engl J Med, 1998. 338(25): p. 1798-804.

202. Adelstein, D. J., Li, Y., Adams, G. L., Wagner, H., Jr., Kish, J. A., Ensley, J. F., et.al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer, J Clin Oncol, 2003. 21(1): p. 92-8.

203. Budach, W., Hehr, T., Budach, V., Belka, C., Dietz, K., A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck, BMC Cancer, 2006. 6: p. 28.

204. Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., et.al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol, 2011. 12(2): p. 127-36.

205. Marta, G. N., Silva, V., de Andrade Carvalho, H., de Arruda, F. F., Hanna, S. A., Gadia, R., et.al. Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis, Radiother Oncol, 2014. 110(1): p. 9-15.

206. Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., et.al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol, 2011. 12(2): p. 127-36.

207. Marta, G. N., Silva, V., de Andrade Carvalho, H., de Arruda, F. F., Hanna, S. A., Gadia, R., et.al. Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis, Radiother Oncol, 2014. 110(1): p. 9-15.

208. Nuyts, S., Lambrecht, M., Duprez, F., Daisne, J. F., Van Gestel, D., Van den Weyngaert, D., et.al. Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity, Radiother Oncol, 2013. 109(2): p. 323-9.

209. Peters, L. J., Goepfert, H., Ang, K. K., Byers, R. M., Maor, M. H., Guillamondegui, O., et.al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial, Int J Radiat Oncol Biol Phys, 1993. 26(1): p. 3-11.

210. Withers, H. R., Peters, L. J., Taylor, J. M., Dose-response relationship for radiation therapy of subclinical disease, Int J Radiat Oncol Biol Phys, 1995. 31(2): p. 353-9.

211. Dische, S., Saunders, M., Barrett, A., Harvey, A., Gibson, D., Parmar, M., A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer, Radiother Oncol, 1997. 44(2): p. 123-36.

212. Nguyen-Tan, P. F., Zhang, Q., Ang, K. K., Weber, R. S., Rosenthal, D. I., Soulieres, D., et.al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity, J Clin Oncol, 2014. 32(34): p. 3858-66.

213. Ghadjar, P., Simcock, M., Studer, G., Allal, A. S., Ozsahin, M., Bernier, J., et.al. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94), Int J Radiat Oncol Biol Phys, 2012. 82(2): p. 524-31.

214. Bensadoun, R. J., Benezery, K., Dassonville, O., Magne, N., Poissonnet, G., Ramaioli, A., et.al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC), Int J Radiat Oncol Biol Phys, 2006. 64(4): p. 983-94.

215. Blanchard, P., Hill, C., Guihenneuc-Jouyaux, C., Baey, C., Bourhis, J., Pignon, J. P., et.al. Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer, J Clin Epidemiol, 2011. 64(9): p. 985-92.

216. Dietz, A., Rudat, V., Nollert, J., Helbig, M., Vanselow, B., Weidauer, H., Das chronische Larynxödem als Spätreaktion nach Radiochemotherapie. [Chronic laryngeal edema as a late reaction to radiochemotherapy], HNO, 1998. 46(8): p. 731-8.

217. Mancuso, A. A., Mukherji, S. K., Schmalfuss, I., Mendenhall, W., Parsons, J., Pameijer, F., et.al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma, J Clin Oncol, 1999. 17(2): p. 631-7.

218. Pfreundner, L., Hoppe, F., Willner, J., Preisler, V., Bratengeier, K., Hagen, R., et.al. Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation, Radiother Oncol, 2003. 68(2): p. 163-70.

219. Gregoire, V., Eisbruch, A., Hamoir, M., Levendag, P., Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck, Radiother Oncol, 2006. 79(1): p. 15-20.

220. Gregoire, V., Ang, K., Budach, W., Grau, C., Hamoir, M., Langendijk, J. A., et.al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines, Radiother Oncol, 2014. 110(1): p. 172-81.

221. Brouwer, C. L., Steenbakkers, R. J., Bourhis, J., Budach, W., Grau, C., Gregoire, V., et.al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines, Radiother Oncol, 2015. 117(1): p. 83-90.

222. Department of Veterans Affairs Laryngeal Cancer Study, Group, Wolf, G. T., Fisher, S. G., Hong, W. K., Hillman, R., Spaulding, M., et.al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer, N Engl J Med, 1991. 324(24): p. 1685-90.

223. Terrell, J. E., Fisher, S. G., Wolf, G. T., Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group, Arch Otolaryngol Head Neck Surg, 1998. 124(9): p. 964-71.

224. Lefebvre, J. L., Chevalier, D., Luboinski, B., Kirkpatrick, A., Collette, L., Sahmoud, T., Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group, J Natl Cancer Inst, 1996. 88(13): p. 890-9.

225. Lefebvre, J. L., Andry, G., Chevalier, D., Luboinski, B., Collette, L., Traissac, L., et.al. Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891, Ann Oncol, 2012. 23(10): p. 2708-14.

226. Grover, S., Swisher-McClure, S., Mitra, N., Li, J., Cohen, R. B., Ahn, P. H., et.al. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes, Int J Radiat Oncol Biol Phys, 2015. 92(3): p. 594-601.

227. Lefebvre, J. L., Ang, K. K., Larynx Preservation Consensus, Panel, Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary, Head Neck, 2009. 31(4): p. 429-41.

228. Lefebvre, J. L., Ang, K. K., Larynx Preservation Consensus, Panel, Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary, Int J Radiat Oncol Biol Phys, 2009. 73(5): p. 1293-303.

229. Pointreau, Y., Garaud, P., Chapet, S., Sire, C., Tuchais, C., Tortochaux, J., et.al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation, J Natl Cancer Inst, 2009. 101(7): p. 498-506.

230. Blanchard, P., Bourhis, J., Lacas, B., Posner, M. R., Vermorken, J. B., Cruz Hernandez, J. J., et.al. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group, J Clin Oncol, 2013. 31(23): p. 2854-60.

231. Timmermans, A. J., van Dijk, B. A., Overbeek, L. I., van Velthuysen, M. L., van Tinteren, H., Hilgers, F. J., et.al. Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands, Head Neck, 2016. 38 Suppl 1: p. E1247-55.

232. Sanabria, A., Chaves, A. L. F., Kowalski, L. P., Wolf, G. T., Saba, N. F., Forastiere, A. A., et.al. Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials, Auris Nasus Larynx, 2017. 44(1): p. 18-25.

233. Forastiere, A. A., Weber, R. S., Trotti, A., Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes, J Clin Oncol, 2015. 33(29): p. 3262-8.

234. Hurst, N. J., Jr., Dominello, M., Dyson, G., Jaratli, H., Sharma, M., Ahmed, Y. K., et.al. Intratumoral lymphatic vessel density as a predictor of progression-free and overall survival in locally advanced laryngeal/hypopharyngeal cancer, Head Neck, 2016. 38 Suppl 1: p. E417-20.

235. Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., et.al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501), Head Neck, 2005. 27(10): p. 843-50.

236. Bernier, J., Domenge, C., Ozsahin, M., Matuszewska, K., Lefebvre, J. L., Greiner, R. H., et.al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer, N Engl J Med, 2004. 350(19): p. 1945-52.

237. Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B., et.al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck, N Engl J Med, 2004. 350(19): p. 1937-44.

238. Fietkau, R., Lautenschläger, C., Sauer, R., Dunst, J., Becker, A., Baumann, M., et.al. Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: Results of the German phase III trial ARO 96–3, Journal of Clinical Oncology, 2006. 24(18_suppl): p. 5507-5507.

239. Kao, J., Lavaf, A., Teng, M. S., Huang, D., Genden, E. M., Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage, Int J Radiat Oncol Biol Phys, 2008. 71(2): p. 362-70.

240. Tupchong, L., Scott, C. B., Blitzer, P. H., Marcial, V. A., Lowry, L. D., Jacobs, J. R., et.al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03, Int J Radiat Oncol Biol Phys, 1991. 20(1): p. 21-8.

241. Langendijk, J. A., Ferlito, A., Takes, R. P., Rodrigo, J. P., Suarez, C., Strojan, P., et.al. Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck, Oral Oncol, 2010. 46(8): p. 577-85.

242. Mohr, C., Bohndorf, W., Gremmel, H., Härle, F., Hausamen, J. E., Hirche, H., et.al. Preoperative Radiochemotherapy and Radical Surgery of Advanced Head and Neck Cancers - Results of a Prospective Multicenter DÖSAK Study, in Carcinoma of the Oral Cavity and Oropharynx, Pape, H. D.Ganzer, U. and Schmitt, G., Editors. 1994, Springer: Berlin, Heidelberg. p. 155-163.

243. Cooper, S. L., Russo, J. K., Chin, S., Definitive chemoradiotherapy for esophageal carcinoma, Surg Clin North Am, 2012. 92(5): p. 1213-48.

244. Bernier, J., Horiot, J. C., Altered-fractionated radiotherapy in locally advanced head and neck cancer, Curr Opin Oncol, 2012. 24(3): p. 223-8.

245. Huang, J., Barbera, L., Brouwers, M., Browman, G., Mackillop, W. J., Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review, J Clin Oncol, 2003. 21(3): p. 555-63.

246. Marshak, G., Rakowsky, E., Schachter, J., Shvero, J., Feinmesser, R., Sulkes, A., et.al. Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?, Otolaryngol Head Neck Surg, 2004. 131(4): p. 489-93.

247. Suwinski, R., Sowa, A., Rutkowski, T., Wydmanski, J., Tarnawski, R., Maciejewski, B., Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients, Int J Radiat Oncol Biol Phys, 2003. 56(2): p. 399-412.

248. Christianen, M. E., Langendijk, J. A., Westerlaan, H. E., van de Water, T. A., Bijl, H. P., Delineation of organs at risk involved in swallowing for radiotherapy treatment planning, Radiother Oncol, 2011. 101(3): p. 394-402.

249. Nawka, T., Hosemann, W., [Voice disorder. Surgical procedures], Laryngorhinootologie, 2005. 84 Suppl 1: p. S201-12.

250. Arens, C., Herrmann, I. F., Rohrbach, S., Schwemmle, C., Nawka, T., Positionspapier der DGHNO und der DGPP - Stand der klinischen und endoskopischen Diagnostik, Evaluation und Therapie von Schluckstörungen bei Kindern und Erwachsenen. [Position paper of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery and the German Society of Phoniatrics and Pediatric Audiology - current state of clinical and endoscopic diagnostics, evaluation, and therapy of swallowing disorders in children and adults], Laryngorhinootologie, 2015. 94 Suppl 1: p. S306-54.

251. Langmore, S.E., Endoscopic evaluation and treatment of swallowing disordersThieme, 2000.

252. Murray, J., The laryngoscopic evaluation of swallowing or fees, in Manual of Dysphagia Assessment in Adults, Murray, J. , Editor. 1998, Singular Publishing: Norwich. p. 153-190.

253. Wichmann, G., Kruger, A., Boehm, A., Kolb, M., Hofer, M., Fischer, M., et.al. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and (18)F-FDG-PET/CT, Eur J Cancer, 2017. 72: p. 144-155.

254. Trotti, A., Pajak, T. F., Gwede, C. K., Paulus, R., Cooper, J., Forastiere, A., et.al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group, Lancet Oncol, 2007. 8(7): p. 613-24.

255. Machtay, M., Moughan, J., Trotti, A., Garden, A. S., Weber, R. S., Cooper, J. S., et.al. Pre-treatment and treatment related risk factors for severe late toxicity after chemo-RT for head and neck cancer: An RTOG analysis, Journal of Clinical Oncology, 2006. 24(18_suppl): p. 5500-5500.

256. Petkar, I., Bhide, S., Newbold, K., Harrington, K., Nutting, C., Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?, Clin Oncol (R Coll Radiol), 2017. 29(7): p. e110-e118.

257. Zbaren, P., Nuyens, M., Curschmann, J., Stauffer, E., Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas, Head Neck, 2007. 29(1): p. 26-32.

258. Langendijk, J. A., Doornaert, P., Verdonck-de Leeuw, I. M., Leemans, C. R., Aaronson, N. K., Slotman, B. J., Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy, J Clin Oncol, 2008. 26(22): p. 3770-6.

259. Machtay, M., Moughan, J., Trotti, A., Garden, A. S., Weber, R. S., Cooper, J. S., et.al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis, J Clin Oncol, 2008. 26(21): p. 3582-9.

260. Rosenthal, D. I., Mohamed, A. S., Weber, R. S., Garden, A. S., Sevak, P. R., Kies, M. S., et.al. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey, Cancer, 2015. 121(10): p. 1608-19.

261. Dietz, A., Nollert, J., Eckel, H., Volling, P., Schroder, M., Staar, S., et.al. Organerhalt beim fortgeschrittenen Larynx- bzw. Hypopharynxkarzinom durch primäre Radiochemotherapie. Ergebnisse einer multizentrischen Phase-II-Studie. [Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study], HNO, 2002. 50(2): p. 146-54.

262. Dietz, A., Rudat, V., Dreyhaupt, J., Pritsch, M., Hoppe, F., Hagen, R., et.al. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial), Eur Arch Otorhinolaryngol, 2009. 266(8): p. 1291-300.

263. Rosenthal, D. I., Lewin, J. S., Eisbruch, A., Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer, J Clin Oncol, 2006. 24(17): p. 2636-43.

264. Tolep, K., Getch, C. L., Criner, G. J., Swallowing dysfunction in patients receiving prolonged mechanical ventilation, Chest, 1996. 109(1): p. 167-72.

265. Waters, T. M., Logemann, J. A., Pauloski, B. R., Rademaker, A. W., Lazarus, C. L., Newman, L. A., et.al. Beyond efficacy and effectiveness: conducting economic analyses during clinical trials, Dysphagia, 2004. 19(2): p. 109-19.

266. Kulbersh, B. D., Rosenthal, E. L., McGrew, B. M., Duncan, R. D., McColloch, N. L., Carroll, W. R., et.al. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life, Laryngoscope, 2006. 116(6): p. 883-6.

267. Curtin, H. D., Imaging of the larynx: current concepts, Radiology, 1989. 173(1): p. 1-11.

268. Robbins, K. T., Shaha, A. R., Medina, J. E., Califano, J. A., Wolf, G. T., Ferlito, A., et.al. Consensus statement on the classification and terminology of neck dissection, Arch Otolaryngol Head Neck Surg, 2008. 134(5): p. 536-8.

269. Ferlito, A., Silver, C. E., Rinaldo, A., Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma, Laryngoscope, 2008. 118(4): p. 676-9.

270. Ghouri, A. F., Zamora, R. L., Sessions, D. G., Spitznagel, E. L., Jr., Harvey, J. E., Prediction of occult neck disease in laryngeal cancer by means of a logistic regression statistical model, Laryngoscope, 1994. 104(10): p. 1280-4.

271. Johnson, J. T., Myers, E. N., Hao, S. P., Wagner, R. L., Outcome of open surgical therapy for glottic carcinoma, Ann Otol Rhinol Laryngol, 1993. 102(10): p. 752-5.

272. Ramadan, H. H., Allen, G. C., The influence of elective neck dissection on neck relapse in NO supraglottic carcinoma, Am J Otolaryngol, 1993. 14(4): p. 278-81.

273. Deganello, A., Gitti, G., Meccariello, G., Parrinello, G., Mannelli, G., Gallo, O., Effectiveness and pitfalls of elective neck dissection in N0 laryngeal cancer, Acta Otorhinolaryngol Ital, 2011. 31(4): p. 216-21.

274. Howell-Burke, D., Peters, L. J., Goepfert, H., Oswald, M. J., T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy, Arch Otolaryngol Head Neck Surg, 1990. 116(7): p. 830-5.

275. Samant, S., Robbins, K. T., Evolution of neck dissection for improved functional outcome, World J Surg, 2003. 27(7): p. 805-10.

276. Bocca, E., Calearo, C., de Vincentiis, I., Marullo, T., Motta, G., Ottaviani, A., Occult metastases in cancer of the larynx and their relationship to clinical and histological aspects of the primary tumor: a four-year multicentric research, Laryngoscope, 1984. 94(8): p. 1086-90.

277. Erdag, T. K., Guneri, E. A., Avincsal, O., Sarioglu, S., Ecevit, M. C., Guneri, A., et.al. Is elective neck dissection necessary for the surgical management of T2N0 glottic carcinoma?, Auris Nasus Larynx, 2013. 40(1): p. 85-8.

278. Fein, D. A., Hanlon, A. L., Lee, W. R., Ridge, J. A., Coia, L. R., Neck failure in T2N0 squamous cell carcinoma of the true vocal cords: the Fox Chase experience and review of the literature, Am J Clin Oncol, 1997. 20(2): p. 154-7.

279. Gallo, O., Deganello, A., Scala, J., De Campora, E., Evolution of elective neck dissection in N0 laryngeal cancer, Acta Otorhinolaryngol Ital, 2006. 26(6): p. 335-44.

280. Mendenhall, W. M., Parsons, J. T., Brant, T. A., Stringer, S. P., Cassisi, N. J., Million, R. R., Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx?, Radiother Oncol, 1989. 14(3): p. 199-202.

281. Spector, J. G., Sessions, D. G., Chao, K. S., Hanson, J. M., Simpson, J. R., Perez, C. A., Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery, Head Neck, 1999. 21(2): p. 116-23.

282. Terhaard, C. H., Hordijk, G. J., van den Broek, P., de Jong, P. C., Snow, G. B., Hilgers, F. J., et.al. T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results, Clin Otolaryngol Allied Sci, 1992. 17(5): p. 393-402.

283. Yang, C. Y., Andersen, P. E., Everts, E. C., Cohen, J. I., Nodal disease in purely glottic carcinoma: is elective neck treatment worthwhile?, Laryngoscope, 1998. 108(7): p. 1006-8.

284. Gallo, O., Fini-Storchi, I., Napolitano, L., Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-3), Head Neck, 2000. 22(4): p. 386-92.

285. Hilly, O., Gil, Z., Goldhaber, D., Amit, M., Biadsee, A., Popovtzer, A., et.al. Elective neck dissection during salvage total laryngectomy--a beneficial prognostic effect in locally advanced recurrent tumours, Clin Otolaryngol, 2015. 40(1): p. 9-15.

286. Pantel, M., Wittekindt, C., Altendorf-Hofmann, A., Boeger, D., Buentzel, J., Esser, D., et.al. Diversity of treatment of T2N0 glottic cancer of the larynx: lessons to learn from epidemiological cancer registry data, Acta Otolaryngol, 2011. 131(11): p. 1205-13.

287. Robbins, K. T., Shaha, A. R., Medina, J. E., Califano, J. A., Wolf, G. T., Ferlito, A., et.al. Consensus statement on the classification and terminology of neck dissection, Arch Otolaryngol Head Neck Surg, 2008. 134(5): p. 536-8.

288. Schröder, U., Aktueller Stellenwert der offenen Larynxteilresektion unter besonderer Berücksichtigung der suprakrikoidalen Teilresektionen. [Current value of open-preservation surgery with special emphasis given to the supracricoid laryngectomy], Laryngorhinootologie, 2007. 86(7): p. 490-9.

289. Sparano, A., Chernock, R., Feldman, M., Laccourreye, O., Brasnu, D., Weinstein, G., Extending the inferior limits of supracricoid partial laryngectomy: a clinicopathological correlation, Laryngoscope, 2005. 115(2): p. 297-300.

290. Schröder, U., Wollenberg, B., Bruchhage, K. L., Stellenwert der suprakrikoidalen Teilresektion beim moderat fortgeschrittenen Glottiskarzinom (T3-T4a). [The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)], HNO, 2015. 63(11): p. 741-6.

291. Dietz, A., Kopf-Hals-Tumoren - Therapie des Larynx-/Hypopharynxkarzinoms unter besonderer Berücksichtigung des LarynxorganerhaltsUNI-MED, 2008.

292. Kleinsasser, O., Tumoren des Larynx und des HypopharynxThieme, 1987.

293. Bootz, F., Keiner, S., Rekonstruktionsverfahren zum Wiederaufbau des Hypopharynx nach Tumorexstirpation. [Reconstructive procedures for restoring the hypopharynx after tumor excision], HNO, 1998. 46(2): p. 87-9.

294. Remmert, S., Müller, G., Weerda, H., Revaskularisierte überlange Jejunumsegmente in der einzeitigen Wiederherstellung von Stimm- und Schluckfunktion nach totaler Laryngopharyngektomie. [Revascularized over-long jejunum segments in single stage reconstruction of voice and deglutition function after total laryngopharyngectomy], HNO, 1993. 41(10): p. 485-90.

295. Remmert, S., Ahrens, K. H., Sommer, K., Muller, G., Weerda, H., Die Stimmrehabilitation mit dem Jejunumsprechsiphon: Der Biventerzugel, eine Modifikation zur Vermeidung von Aspirationen. [Voice rehabilitation with the jejunum speech siphon: the biventer rein, a modification for prevention of aspiration], Laryngorhinootologie, 1994. 73(2): p. 84-7.

296. Gemeinsamer Bundesausschuss (G-BA), Tragende Gründe zum Beschluss des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinie Methoden vertragsärztliche Versorgung: Positronenemissionstomographie (PET) PET / Computertomographie (CT) bei Kopf-Hals-Tumoren vom 16. März 2017G-BA, 2017.

297. van der Putten, L., de Bree, R., Kuik, D. J., Rietveld, D. H., Buter, J., Eerenstein, S. E., et.al. Salvage laryngectomy: oncological and functional outcome, Oral Oncol, 2011. 47(4): p. 296-301.

298. Viani, L., Stell, P. M., Dalby, J. E., Recurrence after radiotherapy for glottic carcinoma, Cancer, 1991. 67(3): p. 577-84.

299. Santoro, R., Bini, B., Mannelli, G., Meccariello, G., Paiar, F., Gallo, O., Salvage surgery after unsuccessful radiotherapy in early glottic cancer, B-ENT, 2014. 10(2): p. 113-20.

300. de Vincentiis, Marco, De Virgilio, Armando, Bussu, Francesco, Gallus, Roberto, Gallo, Andrea, Bastanza, Giovanni, et.al. Oncologic results of the surgical salvage of recurrent laryngeal squamous cell carcinoma in a multicentric retrospective series: Emerging role of supracricoid partial laryngectomy, Head & Neck, 2015. 37(1): p. 84-91.

301. Pukander, J., Kerala, J., Makitie, A., Hyrynkangas, K., Virtaniemi, J., Grenman, R., Endoscopic laser surgery for laryngeal cancer, Eur Arch Otorhinolaryngol, 2001. 258(5): p. 236-9.

302. Roedel, R. M., Matthias, C., Wolff, H. A., Schindler, P., Aydin, T., Christiansen, H., Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic cancer, Auris Nasus Larynx, 2010. 37(4): p. 474-81.

303. Ramakrishnan, Y., Drinnan, M., Kwong, F. N., Grant, D. G., Mehanna, H., Jones, T., et.al. Oncologic outcomes of transoral laser microsurgery for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature, Head Neck, 2014. 36(2): p. 280-5.

304. Paleri, V., Thomas, L., Basavaiah, N., Drinnan, M., Mehanna, H., Jones, T., Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature, Cancer, 2011. 117(12): p. 2668-76.

305. Laccourreye, O., Weinstein, G., Naudo, P., Cauchois, R., Laccourreye, H., Brasnu, D., Supracricoid partial laryngectomy after failed laryngeal radiation therapy, Laryngoscope, 1996. 106(4): p. 495-8.

306. Leon, X., Lopez, M., Garcia, J., Viza, I., Orus, C., Quer, M., Supracricoid laryngectomy as salvage surgery after failure of radiation therapy, Eur Arch Otorhinolaryngol, 2007. 264(7): p. 809-14.

307. Marioni, G., Marchese-Ragona, R., Pastore, A., Staffieri, A., The role of supracricoid laryngectomy for glottic carcinoma recurrence after radiotherapy failure: a critical review, Acta Otolaryngol, 2006. 126(12): p. 1245-51.

308. Mooney, W. W., Cole, I., Albsoul, N., Pearson, S. A., Salvage vertical partial laryngectomy for radiation failure in early glottic carcinoma, ANZ J Surg, 2002. 72(10): p. 746-9.

309. Nichols, R. D., Mickelson, S. A., Partial laryngectomy after irradiation failure, Ann Otol Rhinol Laryngol, 1991. 100(3): p. 176-80.

310. Pellini, R., Manciocco, V., Spriano, G., Functional outcome of supracricoid partial laryngectomy with cricohyoidopexy: radiation failure vs previously untreated cases, Arch Otolaryngol Head Neck Surg, 2006. 132(11): p. 1221-5.

311. Pellini, R., Pichi, B., Ruscito, P., Ceroni, A. R., Caliceti, U., Rizzotto, G., et.al. Supracricoid partial laryngectomies after radiation failure: a multi-institutional series, Head Neck, 2008. 30(3): p. 372-9.

312. Strauss, M., Hemilaryngectomy rescue surgery for radiation failure in early glottic carcinoma, Laryngoscope, 1988. 98(3): p. 317-20.

313. Toma, M., Nibu, K., Nakao, K., Matsuzaki, M., Mochiki, M., Yuge, T., et.al. Partial laryngectomy to treat early glottic cancer after failure of radiation therapy, Arch Otolaryngol Head Neck Surg, 2002. 128(8): p. 909-12.

314. Watters, G. W., Patel, S. G., Rhys-Evans, P. H., Partial laryngectomy for recurrent laryngeal carcinoma, Clin Otolaryngol Allied Sci, 2000. 25(2): p. 146-52.

315. Grant, D. G., Salassa, J. R., Hinni, M. L., Pearson, B. W., Hayden, R. E., Perry, W. C., Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer, Otolaryngol Head Neck Surg, 2008. 138(5): p. 606-13.

316. Quer, M., Leon, X., Orus, C., Venegas, P., Lopez, M., Burgues, J., Endoscopic laser surgery in the treatment of radiation failure of early laryngeal carcinoma, Head Neck, 2000. 22(5): p. 520-3.

317. Agra, I. M., Carvalho, A. L., Pontes, E., Campos, O. D., Ulbrich, F. S., Magrin, J., et.al. Postoperative complications after en bloc salvage surgery for head and neck cancer, Arch Otolaryngol Head Neck Surg, 2003. 129(12): p. 1317-21.

318. Ganly, I., Patel, S. G., Matsuo, J., Singh, B., Kraus, D. H., Boyle, J. O., et.al. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx, Arch Otolaryngol Head Neck Surg, 2006. 132(1): p. 59-66.

319. Goodwin, W. J., Jr., Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?, Laryngoscope, 2000. 110(3 Pt 2 Suppl 93): p. 1-18.

320. Holsinger, F. C., Funk, E., Roberts, D. B., Diaz, E. M., Jr., Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer, Head Neck, 2006. 28(9): p. 779-84.

321. Liang, J. W., Li, Z. D., Li, S. C., Fang, F. Q., Zhao, Y. J., Li, Y. G., Pharyngocutaneous fistula after total laryngectomy: A systematic review and meta-analysis of risk factors, Auris Nasus Larynx, 2015. 42(5): p. 353-9.

322. Putten, L., Bree, R., Doornaert, P. A., Buter, J., Eerenstein, S. E., Rietveld, D. H., et.al. Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review, Acta Otorhinolaryngol Ital, 2015. 35(3): p. 162-72.

323. Dedivitis, R. A., Ribeiro, K. C., Castro, M. A., Nascimento, P. C., Pharyngocutaneous fistula following total laryngectomy, Acta Otorhinolaryngol Ital, 2007. 27(1): p. 2-5.

324. Khan, N. A., Medina, J. E., Sanclement, J. A., Krempl, G. A., Fistula rates after salvage laryngectomy: comparing pectoralis myofascial and myocutaneous flaps, Laryngoscope, 2014. 124(7): p. 1615-7.

325. Patel, U. A., Moore, B. A., Wax, M., Rosenthal, E., Sweeny, L., Militsakh, O. N., et.al. Impact of pharyngeal closure technique on fistula after salvage laryngectomy, JAMA Otolaryngol Head Neck Surg, 2013. 139(11): p. 1156-62.

326. Aires, F. T., Dedivitis, R. A., Castro, M. A., Bernardo, W. M., Cernea, C. R., Brandao, L. G., Efficacy of stapler pharyngeal closure after total laryngectomy: A systematic review, Head Neck, 2014. 36(5): p. 739-42.

327. Jing, S. S., O'Neill, T., Clibbon, J. J., A comparison between free gracilis muscle flap and pedicled pectoralis major flap reconstructions following salvage laryngectomy, J Plast Reconstr Aesthet Surg, 2014. 67(1): p. 17-22.

328. Paleri, V., Drinnan, M., van den Brekel, M. W., Hinni, M. L., Bradley, P. J., Wolf, G. T., et.al. Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review, Laryngoscope, 2014. 124(8): p. 1848-53.

329. Sayles, M., Grant, D. G., Preventing pharyngo-cutaneous fistula in total laryngectomy: a systematic review and meta-analysis, Laryngoscope, 2014. 124(5): p. 1150-63.

330. Schwaab, G., Mamelle, G., Lartigau, E., Parise, O., Jr., Wibault, P., Luboinski, B., Surgical salvage treatment of T1/T2 glottic carcinoma after failure of radiotherapy, Am J Surg, 1994. 168(5): p. 474-5.

331. Shah, J. P., Loree, T. R., Kowalski, L., Conservation surgery for radiation-failure carcinoma of the glottic larynx, Head Neck, 1990. 12(4): p. 326-31.

332. Haraf, D. J., Weichselbaum, R. R., Vokes, E. E., Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease, Ann Oncol, 1996. 7(9): p. 913-8.

333. Pomp, J., Levendag, P. C., van Putten, W. L., Reirradiation of recurrent tumors in the head and neck, Am J Clin Oncol, 1988. 11(5): p. 543-9.

334. Stevens, K. R., Jr., Britsch, A., Moss, W. T., High-dose reirradiation of head and neck cancer with curative intent, Int J Radiat Oncol Biol Phys, 1994. 29(4): p. 687-98.

335. Emami, B., Bignardi, M., Spector, G. J., Devineni, V. R., Hederman, M. A., Reirradiation of recurrent head and neck cancers, Laryngoscope, 1987. 97(1): p. 85-8.

336. Ohizumi, Y., Tamai, Y., Imamiya, S., Akiba, T., Complications following re-irradiation for head and neck cancer, Am J Otolaryngol, 2002. 23(4): p. 215-21.

337. Dawson, L. A., Myers, L. L., Bradford, C. R., Chepeha, D. B., Hogikyan, N. D., Teknos, T. N., et.al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer, Int J Radiat Oncol Biol Phys, 2001. 50(2): p. 377-85.

338. Aaltonen, L. M., Rautiainen, N., Sellman, J., Saarilahti, K., Makitie, A., Rihkanen, H., et.al. Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy, Int J Radiat Oncol Biol Phys, 2014. 90(2): p. 255-60.

339. Spielmann, P. M., Majumdar, S., Morton, R. P., Quality of life and functional outcomes in the management of early glottic carcinoma: a systematic review of studies comparing radiotherapy and transoral laser microsurgery, Clin Otolaryngol, 2010. 35(5): p. 373-82.

340. Cohen, S. M., Garrett, C. G., Dupont, W. D., Ossoff, R. H., Courey, M. S., Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision, Ann Otol Rhinol Laryngol, 2006. 115(8): p. 581-6.

341. Singh, A., Kazi, R., De Cordova, J., Nutting, C. M., Clarke, P., Harrington, K. J., et.al. Multidimensional assessment of voice after vertical partial laryngectomy: a comparison with normal and total laryngectomy voice, J Voice, 2008. 22(6): p. 740-5.

342. Biacabe, B., Crevier-Buchman, L., Hans, S., Laccourreye, O., Brasnu, D., Phonatory mechanisms after vertical partial laryngectomy with glottic reconstruction by false vocal fold flap, Ann Otol Rhinol Laryngol, 2001. 110(10): p. 935-40.

343. Davis, R. K., Kriskovich, M. D., Galloway, E. B., 3rd, Buntin, C. S., Jepsen, M. C., Endoscopic supraglottic laryngectomy with postoperative irradiation, Ann Otol Rhinol Laryngol, 2004. 113(2): p. 132-8.

344. Peretti, G., Piazza, C., Cattaneo, A., De Benedetto, L., Martin, E., Nicolai, P., Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies, Ann Otol Rhinol Laryngol, 2006. 115(11): p. 827-32.

345. Rodrigo, J. P., Suarez, C., Silver, C. E., Rinaldo, A., Ambrosch, P., Fagan, J. J., et.al. Transoral laser surgery for supraglottic cancer, Head Neck, 2008. 30(5): p. 658-66.

346. Prades, J. M., Simon, P. G., Timoshenko, A. P., Dumollard, J. M., Schmitt, T., Martin, C., Extended and standard supraglottic laryngectomies: a review of 110 patients, Eur Arch Otorhinolaryngol, 2005. 262(12): p. 947-52.

347. Sevilla, M. A., Rodrigo, J. P., Llorente, J. L., Cabanillas, R., Lopez, F., Suarez, C., Supraglottic laryngectomy: analysis of 267 cases, Eur Arch Otorhinolaryngol, 2008. 265(1): p. 11-6.

348. Wiskirska-Woznica, B., Leszczynska, M., Swidzinski, Czerniejewska, H., Jackowska, J., Witold, S., Voice estimation in patients after reconstructive subtotal laryngectomy, Head Neck Oncol, 2011. 3: p. 46.

349. Benito, J., Holsinger, F. C., Perez-Martin, A., Garcia, D., Weinstein, G. S., Laccourreye, O., Aspiration after supracricoid partial laryngectomy: Incidence, risk factors, management, and outcomes, Head Neck, 2011. 33(5): p. 679-85.

350. Dicks, P., Laryngektomie: Logopädische Therapie bei KehlkopflosigkeitSchulz-Kirchner, 2007.

351. Ackerstaff, A. H., Hilgers, F. J., Aaronson, N. K., Balm, A. J., van Zandwijk, N., Improvements in respiratory and psychosocial functioning following total laryngectomy by the use of a heat and moisture exchanger, Ann Otol Rhinol Laryngol, 1993. 102(11): p. 878-83.

352. Balle, V. H., Rindso, L., Thomsen, J., Speech rehabilitation by Provox voice prosthesis combined with heat and moisture exchange filters, Acta Otolaryngol Suppl, 1997. 529: p. 251-3.

353. Bundesverband Medizintechnologie (BVMed), Empfehlung für die Versorgung von laryngektomierten Patienten. InformationsbroschüreBVMed, 2014.

354. Seidl, R. O., Nusser-Müller-Busch, R., Trachealkanülen: Segen und Fluch, in Die Therapie des Facio-Oralen Trakts. F.O.T.T. nach Kay Coombes. 4. Auflage, Nusser-Müller-Busch, R. , Editor. 2015, Springer: Berlin, Heidelberg. p. 201-219.

355. Dietz, A., Rudat, V., Nollert, J., Helbig, M., Vanselow, B., Weidauer, H., Das chronische Larynxödem als Spätreaktion nach Radiochemotherapie. [Chronic laryngeal edema as a late reaction to radiochemotherapy], HNO, 1998. 46(8): p. 731-8.

356. Studer, G., Glanzmann, C., Studer, S. P., Gratz, K. W., Lutolf, U. M., Zwahlen, R. A., et.al. Empfehlung für die Zahnsanierung vor intensitats-modulierter Radiotherapie (IMRT). UniversitätsSpital Zurich (USZ)-Richtlinien-Anpassung. [Recommendations for dental care prior to intensity-modulated radiotherapy (IMRT). Adaptation of the University Hospital Zurich (USZ) guidelines], Schweiz Monatsschr Zahnmed, 2007. 117(6): p. 637-47.

357. Grötz, K.A., Prophylaxe und Therapie der Folgen therapeutischer Tumor-Bestrahlung im Mund-, Kiefer- und GesichtsbereichQuintessenz, 2001.

358. Grötz, K. A., Zahnärztliche Betreuung von Patienten mit tumortherapeutischer Kopf-Hals-Bestrahlung. Gemeinsame Stellungnahme der Deutschen Gesellschaft für Zahn, Mund-und Kieferheilkunde, Deutschen Gesellschaft fur Radioonkologie, Medicinische Physik und Strahlenbiologie Abstimmung mit dem Vorstand der Deutschen Gesellschaft für Zahnerhaltungskunde [Dental care for patients with antineoplastic radiotherapy of the head and neck], Strahlenther Onkol, 2003. 179(4): p. 275-8.

359. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Gesellschaft für Radioonkologie (DEGRO), Supportive Maßnahmen in der Radioonkologie. S2e-Leitlinien, Version 1.2. AWMF-Register-Nr.: 052/014AWMF, 2015.

360. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), Deutsche Gesellschaft für Hämatologie und medizinische Onkologie (DGHO), Deutsche Gesellschaft für Radioonkologie (DEGRO), S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen, Version 1.1. AWMF-Register-Nr.: 032/054OLLeitlinienprogramm Onkologie, 2017.

361. Ludwig, E., Zahnärztliche Betreuung bei Tumortherapie der Kopf-Hals-Region. Teil 1: Radiatio. [Dental care in case of head and neck cancer--Part I: Radiotherapy], Laryngorhinootologie, 2008. 87(12): p. 885-97; quiz 898-902.

362. De Moor, R. J., Stassen, I. G., van 't Veldt, Y., Torbeyns, D., Hommez, G. M., Two-year clinical performance of glass ionomer and resin composite restorations in xerostomic head- and neck-irradiated cancer patients, Clin Oral Investig, 2011. 15(1): p. 31-8.

363. Aitasalo, K., Niinikoski, J., Grenman, R., Virolainen, E., A modified protocol for early treatment of osteomyelitis and osteoradionecrosis of the mandible, Head Neck, 1998. 20(5): p. 411-7.

364. Kielbassa, A. M., Meyer-Lueckel, H., Die Auswirkungen von Speichelersatzmitteln und Mundspüllosungen auf Dentin. [Effects of saliva substitutes and mouthwash solutions on dentin], Schweiz Monatsschr Zahnmed, 2001. 111(9): p. 1060-6.

365. Kielbassa, A. M., Shohadai, S. P., Schulte-Monting, J., Effect of saliva substitutes on mineral content of demineralized and sound dental enamel, Support Care Cancer, 2001. 9(1): p. 40-7.

366. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), Deutsche Dermatologische Gesellschaft (DDG), S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms, Version 0.3.0 (Konsultationsfassung). AWMF-Register-Nr.: 032/024OLLeitlinienprogramm Onkologie, 2017.

367. Kähler, K. C., Hauschild, A., Hautveränderungen durch „targeted therapies“, best practice onkologie, 2009. 4(1): p. 42-49.

368. Gutzmer, R., Wollenberg, A., Ugurel, S., Homey, B., Ganser, A., Kapp, A., Cutaneous side effects of new antitumor drugs: clinical features and management, Dtsch Arztebl Int, 2012. 109(8): p. 133-40.

369. Dicks, P., Laryngektomie: Logopädische Therapie bei KehlkopflosigkeitSchulz-Kirchner, 2007.

370. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)), Entwicklung von Leitlinien basierten Qualitätsindikatoren. Methodenpapier für das Leitlinienprogramm Onkologie. Version 2.0. 2017., 2017., http://leitlinienprogramm-onkologie.de/Informationen-zur-Methodik.53.0.html

371. Nusser-Müller-Busch, R., Horst, R., Die Manuelle Schlucktherapie – Reset the brain, FORUM Logopädie, 2011. 25(3): p. 6-13.

372. Seidl, R. O., Nusser-Müller-Busch, R., Schluckrehabilitation nach moderner Tumortherapie im Kopf-Hals-Bereich. [Posttreatment rehabilitation of swallowing in patients with head and neck cancer], Laryngorhinootologie, 2007. 86(12): p. 846-52.

373. Seidl, R. O., Nusser-Müller-Busch, R., Schluckrehabilitation nach moderner Tumortherapie im Kopf-Hals-Bereich. [Posttreatment rehabilitation of swallowing in patients with head and neck cancer], Laryngorhinootologie, 2007. 86(12): p. 846-52.

374. Motzko, M., Mlynczak, U., Prinzen, C., Stimm- und Schlucktherapie nach Larynx- und HypopharynxkarzinomenElsevier, 2004.

375. Bindewald, J., Herrmann, E., Dietz, A., Wulke, C., Meister, E., Wollbruck, D., et.al. Lebensqualität und Sprachverständlichkeit bei Patienten mit Kehlkopfkarzinom - Relevanz des "Zufriedenheitsparadoxes". [Quality of life and voice intelligibility in laryngeal cancer patients--relevance of the "satisfaction paradox"], Laryngorhinootologie, 2007. 86(6): p. 426-30.

376. Meyer, A., Dietz, A., Wollbruck, D., Oeken, J., Danker, H., Meister, E. F., et.al. Schluckstörungen nach Kehlkopfteilresektion. Auftrittshäufigkeit und Prädiktoren. [Swallowing disorders after partial laryngectomy. Prevalence and predictors], HNO, 2012. 60(10): p. 892-900.

377. Bartolome, G., Schröter-Morasch, H., Schluckstörungen: Diagnostik und Rehabilitation. 5. AuflageElsevier, 2013.

378. Lazarus, C. L., Logemann, J. A., Pauloski, B. R., Colangelo, L. A., Kahrilas, P. J., Mittal, B. B., et.al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy, Laryngoscope, 1996. 106(9 Pt 1): p. 1157-66.

379. Gillespie, M. B., Brodsky, M. B., Day, T. A., Lee, F. S., Martin-Harris, B., Swallowing-related quality of life after head and neck cancer treatment, Laryngoscope, 2004. 114(8): p. 1362-7.

380. Wollbruck, D., Danker, H., Ullrich, P., Pabich, J., Singer, S., Psychoonkologie für Logopäden und Sprechwissenschaftler: Begründung und Konzeption des Kurses PSYKOL. [Psycho-oncology for speech therapists: establishment and conception of the course PSYKOL], HNO, 2013. 61(12): p. 1026-31.

381. Motzko, M., Mlynczak, U., Prinzen, C., Stimm- und Schlucktherapie nach Larynx- und HypopharynxkarzinomenElsevier, 2004.

382. Perry, A. R., Shaw, M. A., Cotton, S., An evaluation of functional outcomes (speech, swallowing) in patients attending speech pathology after head and neck cancer treatment(s): results and analysis at 12 months post-intervention, J Laryngol Otol, 2003. 117(5): p. 368-81.

383. Singer, S., Arraras, J. I., Baumann, I., Boehm, A., Chie, W. C., Galalae, R., et.al. Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy--update of the EORTC QLQ-H&N35, Phase I, Head Neck, 2013. 35(9): p. 1331-8.

384. Neumann, A., Schultz-Coulon, H. J., Management von Komplikationen nach prothetischer Stimmrehabilitation. [Management of complications after prosthetic voice rehabilitation], HNO, 2000. 48(7): p. 508-16.

385. Singer, S., Keszte, J., Dietz, A., Kluge, A., Plontke, S., Heim, M., et.al. Berufliche Rehabilitation nach Laryngektomie. [Vocational rehabilitation after total laryngectomy], Laryngorhinootologie, 2013. 92(11): p. 737-45.

386. Herranz, J., Gavilan, J., Psychosocial adjustment after laryngeal cancer surgery, Ann Otol Rhinol Laryngol, 1999. 108(10): p. 990-7.

387. Sako, K., Cardinale, S., Marchetta, F. C., Shedd, D. P., Speech and vocational rehabilitation of the laryngectomized patient, J Surg Oncol, 1974. 6(3): p. 197-202.

388. Laptschenko, S. N., Kuznetsov, V. S., Dormakov, V. V., Guziukina, T. V., Orlova, E. R., [Medico-social and economic aspects of the rehabilitation of patients with laryngeal cancer], Vestn Otorinolaringol, 1990. p. 11-14.

389. Schraub, S., Bontemps, P., Mercier, M., Barthod, L., Fournier, J., [Surveillance and rehabilitation of cancers of upper respiratory and digestive tracts], Rev Prat, 1995. 45(7): p. 861-4.

390. Lazo, V. V., [Possibilities of vocational rehabilitation after laryngectomy for cancer], Zh Ushn Nos Gorl Bolezn, 1976. p. 29-34.

391. Natvig, K., Study No. 4: Social, occupational and personal factors related to vocational rehabilitation, J Otolaryngol, 1983. 12(6): p. 370-6.

392. Bremerich, A., Stoll, W., Die Rehabilitation nach Laryngektomie aus der Sicht der Betroffenen. [Rehabilitation following laryngectomy from the viewpoint of the affected patients], HNO, 1985. 33(5): p. 220-3.

393. Matzker, J., Genschow, J., Wie lebt der Laryngektomierte? Ergebnisse einer Befragung von 90 Laryngektomierten. [How does the patient with laryngectomy live? Results of a survey of 90 patients], Z Laryngol Rhinol Otol, 1970. 49(5): p. 290-300.

394. Mehnert, A., Employment and work-related issues in cancer survivors, Crit Rev Oncol Hematol, 2011. 77(2): p. 109-30.

395. Singer, S., Szalai, C., Briest, S., Brown, A., Dietz, A., Einenkel, J., et.al. Co-morbid mental health conditions in cancer patients at working age--prevalence, risk profiles, and care uptake, Psychooncology, 2013. 22(10): p. 2291-7.

396. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), S3-Leitlinie Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten, Version 1.1. AWMF-Register-Nr.: 032/051OLLeitlinienprogramm Onkologie, 2014.

397. Singer, S., Herrmann, E., Welzel, C., Klemm, E., Heim, M., Schwarz, R., Comorbid mental disorders in laryngectomees, Onkologie, 2005. 28(12): p. 631-6.

398. Singer, S., Bringmann, H., Hauss, J., Kortmann, R. D., Kohler, U., Krauss, O., et.al. Häufigkeit psychischer Begleiterkrankungen und der Wunsch nach psychosozialer Unterstützung bei Tumorpatienten im Akutkrankenhaus. [Prevalence of concomitant psychiatric disorders and the desire for psychosocial help in patients with malignant tumors in an acute hospital], Dtsch Med Wochenschr, 2007. 132(40): p. 2071-6.

399. Mehnert, A., Brahler, E., Faller, H., Harter, M., Keller, M., Schulz, H., et.al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities, J Clin Oncol, 2014. 32(31): p. 3540-6.

400. Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., et.al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer, Cancer, 2000. 88(12): p. 2817-23.

401. Meyer, A., Keszte, J., Wollbruck, D., Dietz, A., Oeken, J., Vogel, H. J., et.al. Psychological distress and need for psycho-oncological support in spouses of total laryngectomised cancer patients-results for the first 3 years after surgery, Support Care Cancer, 2015. 23(5): p. 1331-9.

402. Keller, M., Sommerfeldt, S., Fischer, C., Knight, L., Riesbeck, M., Lowe, B., et.al. Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach, Ann Oncol, 2004. 15(8): p. 1243-9.

403. Singer, S., Brown, A., Einenkel, J., Hauss, J., Hinz, A., Klein, A., et.al. Identifying tumor patients' depression, Support Care Cancer, 2011. 19(11): p. 1697-703.

404. Singer, S., Krauss, O., Keszte, J., Siegl, G., Papsdorf, K., Severi, E., et.al. Predictors of emotional distress in patients with head and neck cancer, Head Neck, 2012. 34(2): p. 180-7.

405. Tschiesner, U., Stier-Jarmer, M., Strieth, S., Singer, S., Dietz, A., Fietkau, R., et.al. Entwicklung eines ICF-basierten Leitfadens für die Beurteilung funktioneller Aspekte bei Kopf-Hals-Tumoren. [Development of an ICF-based clinical practice guideline for the assessment of function in head and neck cancer], Laryngorhinootologie, 2013. 92(5): p. 314-25.

406. Zebralla, V., Pohle, N., Singer, S., Neumuth, T., Dietz, A., Stier-Jarmer, M., et.al. Vorstellung des Screeningsystems (OncoFunction) für Funktionsstörungen im Kopf-Hals-Tumor-Follow-up. [Introduction of the Screening Tool OncoFunction for Functional Follow-up of Head and Neck Patients], Laryngorhinootologie, 2016. 95(2): p. 118-24.

407. Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., Kuffner, R., Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis, J Clin Oncol, 2013. 31(6): p. 782-93.

408. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), S3-Leitlinie Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten, Version 1.1. AWMF-Register-Nr.: 032/051OLLeitlinienprogramm Onkologie, 2014.

409. Penner, H., Bur, T., Nusser-Müller-Busch, R., Oster, P., Logopädisches Vorgehen bei Dysphagien im Rahmen der Palliativmedizin, Palliativmedizin, 2010. 11(02): p. 61-75.

410. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), Deutsche Gesellschaft für Palliativmedizin (DGP), S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Version 1.1. AWMF-Register-Nr.: 128/001OLLeitlinienprogramm Onkologie, 2015.

411. World Health Organization (WHO), Palliative Care. Cancer control: Knowledge into Action. WHO guide for effective programmes. Module 5WHO, 2007.

412. Radbruch, L., Payne, S., European Association for Palliative Care (EAPC), White Paper on standards and norms for hospice and palliative care in Europe: part 1, European Journal of Palliative Care, 2009. 16(6): p. 278-289.

413. Ferris, R. L., Blumenschein, G., Jr., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., et.al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck, N Engl J Med, 2016. 375(19): p. 1856-1867., https://www.ncbi.nlm.nih.gov/pubmed/27718784

414. Ferris, R. L., Blumenschein, G., Jr., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., et.al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck, N Engl J Med, 2016. 375(19): p. 1856-1867., https://www.ncbi.nlm.nih.gov/pubmed/27718784

415. Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., et.al. Platinum-based chemotherapy plus cetuximab in head and neck cancer, N Engl J Med, 2008. 359(11): p. 1116-27.

416. Ferris, R. L., Blumenschein, G., Jr., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., et.al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck, N Engl J Med, 2016. 375(19): p. 1856-1867.

417. Seiwert, T. Y., Burtness, B., Mehra, R., Weiss, J., Berger, R., Eder, J. P., et.al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial, Lancet Oncol, 2016. 17(7): p. 956-965.

418. Bauml, J., Seiwert, T. Y., Pfister, D. G., Worden, F., Liu, S. V., Gilbert, J., et.al. Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study, J Clin Oncol, 2017. 35(14): p. 1542-1549.

419. Haas, I., Hauser, U., Ganzer, U., The dilemma of follow-up in head and neck cancer patients, Eur Arch Otorhinolaryngol, 2001. 258(4): p. 177-83.

420. Boysen, M., Lovdal, O., Tausjo, J., Winther, F., The value of follow-up in patients treated for squamous cell carcinoma of the head and neck, Eur J Cancer, 1992. 28(2-3): p. 426-30.

421. Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J. F., Biorklund, A., et.al. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data, Laryngoscope, 2001. 111(8): p. 1440-52.

422. Gao, S., Li, S., Yang, X., Tang, Q., 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis, Oral Oncol, 2014. 50(3): p. 163-7.

423. Fukuhara, T., Fujiwara, K., Fujii, T., Takeda, K., Matsuda, E., Hasegawa, K., et.al. Usefulness of chest CT scan for head and neck cancer, Auris Nasus Larynx, 2015. 42(1): p. 49-52.

424. Jackel, M. C., Ambrosch, P., Martin, A., Steiner, W., Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery, Laryngoscope, 2007. 117(2): p. 350-6.

425. Preuss, S. F., Cramer, K., Drebber, U., Klussmann, J. P., Eckel, H. E., Guntinas-Lichius, O., Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer, Acta Otolaryngol, 2009. 129(8): p. 881-5.

426. Canis, M., Ihler, F., Martin, A., Matthias, C., Steiner, W., Transoral laser microsurgery for T1a glottic cancer: review of 404 cases, Head Neck, 2015. 37(6): p. 889-95.

427. Remacle, M., Eckel, H. E., Antonelli, A., Brasnu, D., Chevalier, D., Friedrich, G., et.al. Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society, Eur Arch Otorhinolaryngol, 2000. 257(4): p. 227-31.

428. Remacle, M., Van Haverbeke, C., Eckel, H., Bradley, P., Chevalier, D., Djukic, V., et.al. Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies, Eur Arch Otorhinolaryngol, 2007. 264(5): p. 499-504.

429. Shenoy, A. M., Prashanth, V., Shivakumar, T., Chavan, P., Akshay, S., Kumar, R. V., et.al. The utility of second look microlaryngoscopy after trans oral laser resection of laryngeal cancer, Indian J Otolaryngol Head Neck Surg, 2012. 64(2): p. 137-41.

430. Motta, G., Esposito, E., Motta, S., Testa, D., [Microlaryngoscopy treatment of laryngeal dysplasia with CO2 laser], Acta Otorhinolaryngol Ital, 2001. 21(1): p. 32-43.

431. Motta, G., Villari, G., Motta, S., Ripa, G., Cuzzocrea, R., [Use of CO2 laser in conservative surgery of glottic tumors], Acta Otorhinolaryngol Ital, 1991. 11(1): p. 25-34.

432. Piazza, C., Giudice, M., Berlucchi, M., Peretti, G., Antonelli, A. R., Atypical carcinoid tumour of the larynx treated with CO2 laser excision: case report, Acta Otorhinolaryngol Ital, 2003. 23(1): p. 43-6.

433. Wang, Y., Springer, S., Mulvey, C. L., Silliman, N., Schaefer, J., Sausen, M., et.al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas, Sci Transl Med, 2015. 7(293): p. 293ra104.

434. Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., et.al. Detection of circulating tumor DNA in early- and late-stage human malignancies, Sci Transl Med, 2014. 6(224): p. 224ra24.

435. Braig, F., Voigtlaender, M., Schieferdecker, A., Busch, C. J., Laban, S., Grob, T., et.al. Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma, Oncotarget, 2016. 7(28): p. 42988-42995.

436. Wu, X. L., Tu, Q., Faure, G., Gallet, P., Kohler, C., Bittencourt Mde, C., Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis, Sci Rep, 2016. 6: p. 20210.

437. Grisanti, S., Almici, C., Consoli, F., Buglione, M., Verardi, R., Bolzoni-Villaret, A., et.al. Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance, PLoS One, 2014. 9(8): p. e103918.

438. sdafvsdfasdf, 2019.

439. Jager, E. A., Kasperts, N., Caldas-Magalhaes, J., Philippens, M. E., Pameijer, F. A., Terhaard, C. H., et.al. GTV delineation in supraglottic laryngeal carcinoma: interobserver agreement of CT versus CT-MR delineation, Radiat Oncol, 2015. 10: p. 26., https://www.ncbi.nlm.nih.gov/pubmed/25612508

440. (ÄZQ), Ärztliches Zentrum für Qualität in der Medizin, E, Gramsch, JD, Hoppe, G, Jonitz, A, Köhler, al., Ollenschläger G et, Kompendium Q-M-A. Qualitätsmanagement in der ambulanten VersorgungDt. Ärzte-Verl., 2008.

441. Entwicklung von Leitlinien basierten Qualitätsindikatoren. Methodenpapier für das Leitlinienprogramm OnkologieLeitlinienprogramm Onkologie (Deutsche Krebsgesellschaft (DKG), Deutsche Krebshilfe (DKH), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)), 2017.